// Topic
Radar Notes
Short weekly notes on one paper, also shared on LinkedIn: what it shows and what it changes for drug discovery decisions.
-
MolecureAI: an agentic platform that builds safety rules into AI drug design
Autonomous AI systems are steadily evolving, and this paper explores a fascinating approach to drug discovery. MolecureAI introduces an agentic platform designed to generate drug candidates while actively enforcing chemical rules and safety parameters—essentially, building in safeguards directly into the AI’s decision-making process. The authors…